nodes	percent_of_prediction	percent_of_DWPC	metapath
Fencamfamine—SLC6A3—Clearance of dopamine—COMT—prostate cancer	0.0921	0.1	CbGpPWpGaD
Fencamfamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—SLC22A1—prostate cancer	0.0712	0.0774	CbGpPWpGaD
Fencamfamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—prostate cancer	0.0603	0.0656	CbGpPWpGaD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—ASCL1—prostate cancer	0.0493	0.0536	CbGpPWpGaD
Fencamfamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—prostate cancer	0.042	0.0457	CbGpPWpGaD
Fencamfamine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC22A1—prostate cancer	0.0356	0.0387	CbGpPWpGaD
Fencamfamine—Tranylcypromine—CYP2A6—prostate cancer	0.0281	0.35	CrCbGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—PLCB2—prostate cancer	0.0252	0.0275	CbGpPWpGaD
Fencamfamine—SLC6A3—Amine compound SLC transporters—SLC22A1—prostate cancer	0.0247	0.0269	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—CASP6—prostate cancer	0.0235	0.0255	CbGpPWpGaD
Fencamfamine—Tranylcypromine—CYP2E1—prostate cancer	0.0199	0.248	CrCbGaD
Fencamfamine—SLC6A3—Monoamine Transport—ACHE—prostate cancer	0.0199	0.0216	CbGpPWpGaD
Fencamfamine—Tranylcypromine—CYP2C19—prostate cancer	0.0197	0.246	CrCbGaD
Fencamfamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.0184	0.02	CbGpPWpGaD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—TH—prostate cancer	0.0172	0.0187	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—CBR1—prostate cancer	0.0168	0.0183	CbGpPWpGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—TH—prostate cancer	0.0167	0.0182	CbGpPWpGaD
Fencamfamine—SLC6A3—Monoamine Transport—TH—prostate cancer	0.0163	0.0177	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GSTM3—prostate cancer	0.0147	0.016	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—TH—prostate cancer	0.0142	0.0155	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—CASP9—prostate cancer	0.0137	0.0149	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—SLC39A1—prostate cancer	0.0133	0.0144	CbGpPWpGaD
Fencamfamine—Tranylcypromine—CYP3A4—prostate cancer	0.0126	0.156	CrCbGaD
Fencamfamine—SLC6A3—Monoamine Transport—ITGB3—prostate cancer	0.012	0.0131	CbGpPWpGaD
Fencamfamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.0119	0.0129	CbGpPWpGaD
Fencamfamine—SLC6A3—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.0106	0.0115	CbGpPWpGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—BAD—prostate cancer	0.00997	0.0108	CbGpPWpGaD
Fencamfamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.00967	0.0105	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—KCNN3—prostate cancer	0.0093	0.0101	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GSTA3—prostate cancer	0.00897	0.00975	CbGpPWpGaD
Fencamfamine—SLC6A3—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.00836	0.00909	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GSTA4—prostate cancer	0.0082	0.00892	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GSTA2—prostate cancer	0.00799	0.00869	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GSTA1—prostate cancer	0.00771	0.00838	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—RRAS—prostate cancer	0.0075	0.00815	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—HSP90AB1—prostate cancer	0.00746	0.00811	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—NFE2L2—prostate cancer	0.00679	0.00739	CbGpPWpGaD
Fencamfamine—SLC6A3—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.00665	0.00723	CbGpPWpGaD
Fencamfamine—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.00665	0.00723	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GPX3—prostate cancer	0.00648	0.00705	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—TGFA—prostate cancer	0.00648	0.00705	CbGpPWpGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—SRC—prostate cancer	0.00593	0.00645	CbGpPWpGaD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—STAT3—prostate cancer	0.00587	0.00638	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—CYP2A6—prostate cancer	0.00584	0.00635	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—CASP3—prostate cancer	0.00578	0.00629	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—RRAS—prostate cancer	0.00574	0.00625	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—PLCB2—prostate cancer	0.00568	0.00618	CbGpPWpGaD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—prostate cancer	0.00544	0.00592	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—SLC22A1—prostate cancer	0.00542	0.00589	CbGpPWpGaD
Fencamfamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.00539	0.00586	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.00538	0.00585	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—GNG5—prostate cancer	0.00516	0.00561	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—SLC5A5—prostate cancer	0.00509	0.00553	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—NQO1—prostate cancer	0.00491	0.00534	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—HSPA1A—prostate cancer	0.00488	0.0053	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—ACHE—prostate cancer	0.0046	0.005	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—EGR1—prostate cancer	0.00456	0.00496	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GGT1—prostate cancer	0.00456	0.00496	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.0044	0.00478	CbGpPWpGaD
Fencamfamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.00439	0.00478	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—PLCB2—prostate cancer	0.00435	0.00473	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—RXRA—prostate cancer	0.00427	0.00465	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00425	0.00462	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—SLC22A1—prostate cancer	0.00415	0.00452	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GSTP1—prostate cancer	0.0041	0.00445	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—TGFBR2—prostate cancer	0.0041	0.00445	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—GNG5—prostate cancer	0.00395	0.00429	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GSTM1—prostate cancer	0.00376	0.00409	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—ACHE—prostate cancer	0.00352	0.00383	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00347	0.00377	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00338	0.00367	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00338	0.00367	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—PRKACB—prostate cancer	0.00337	0.00366	CbGpPWpGaD
Fencamfamine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.00321	0.00349	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—COMT—prostate cancer	0.0032	0.00348	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00274	0.00298	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.00253	0.00275	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—COMT—prostate cancer	0.00245	0.00267	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.00223	0.00243	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—GNG5—prostate cancer	0.00212	0.00231	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.00181	0.00197	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—MDM2—prostate cancer	0.00171	0.00186	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.00171	0.00186	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.00163	0.00177	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—TGFB1—prostate cancer	0.00153	0.00167	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.00144	0.00156	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—RXRA—prostate cancer	0.00137	0.00149	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—MDM2—prostate cancer	0.00131	0.00143	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—PPARA—prostate cancer	0.00105	0.00114	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.00083	0.000903	CbGpPWpGaD
